Global Bioactive Peptides in Cosmetics Market Growth 2024-2030

Publication ID:

LPI08244067

Publication Date:

August 7, 2024

Pages:

132

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

Bioactive peptides in cosmetics refer to short chains of amino acids that are used in skincare and cosmetic products due to their beneficial effects on the skin. These peptides can influence various biological processes and offer a range of skincare benefits, making them popular ingredients in anti-aging, moisturizing, and restorative skincare formulations.
The global Bioactive Peptides in Cosmetics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淏ioactive Peptides in Cosmetics Industry Forecast鈥� looks at past sales and reviews total world Bioactive Peptides in Cosmetics sales in 2023, providing a comprehensive analysis by region and market sector of projected Bioactive Peptides in Cosmetics sales for 2024 through 2030. With Bioactive Peptides in Cosmetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioactive Peptides in Cosmetics industry.
This Insight Report provides a comprehensive analysis of the global Bioactive Peptides in Cosmetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioactive Peptides in Cosmetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bioactive Peptides in Cosmetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioactive Peptides in Cosmetics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioactive Peptides in Cosmetics.
United States market for Bioactive Peptides in Cosmetics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Bioactive Peptides in Cosmetics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Bioactive Peptides in Cosmetics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Bioactive Peptides in Cosmetics players cover Active Peptide Company, Croda International, Ashland, DSM, Bachem, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioactive Peptides in Cosmetics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Whitening Peptides
Anti-wrinkle Peptides
Anti-aging Peptides
Hair Growth Peptides
Other
Segmentation by Application:
Skin Care Products
Daily Products
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Active Peptide Company
Croda International
Ashland
DSM
Bachem
GenScript
AmbioPharm
LifeTein
Creative Peptides
RS Synthesis
Bio Basic
BASF
Activotec
PolyPeptide
Zhejiang Peptites Biotech
Shenzhen Winkey Technology
Guangdong Jianyuan Pharmaceutical
Shenzhen Readline Biotech
National Peptide Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bioactive Peptides in Cosmetics market?
What factors are driving Bioactive Peptides in Cosmetics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bioactive Peptides in Cosmetics market opportunities vary by end market size?
How does Bioactive Peptides in Cosmetics break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bioactive Peptides in Cosmetics Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Bioactive Peptides in Cosmetics by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Bioactive Peptides in Cosmetics by Country/Region, 2019, 2023 & 2030
2.2 Bioactive Peptides in Cosmetics Segment by Type
2.2.1 Whitening Peptides
2.2.2 Anti-wrinkle Peptides
2.2.3 Anti-aging Peptides
2.2.4 Hair Growth Peptides
2.2.5 Other
2.3 Bioactive Peptides in Cosmetics Sales by Type
2.3.1 Global Bioactive Peptides in Cosmetics Sales Market Share by Type (2019-2024)
2.3.2 Global Bioactive Peptides in Cosmetics Revenue and Market Share by Type (2019-2024)
2.3.3 Global Bioactive Peptides in Cosmetics Sale Price by Type (2019-2024)
2.4 Bioactive Peptides in Cosmetics Segment by Application
2.4.1 Skin Care Products
2.4.2 Daily Products
2.4.3 Others
2.5 Bioactive Peptides in Cosmetics Sales by Application
2.5.1 Global Bioactive Peptides in Cosmetics Sale Market Share by Application (2019-2024)
2.5.2 Global Bioactive Peptides in Cosmetics Revenue and Market Share by Application (2019-2024)
2.5.3 Global Bioactive Peptides in Cosmetics Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Bioactive Peptides in Cosmetics Breakdown Data by Company
3.1.1 Global Bioactive Peptides in Cosmetics Annual Sales by Company (2019-2024)
3.1.2 Global Bioactive Peptides in Cosmetics Sales Market Share by Company (2019-2024)
3.2 Global Bioactive Peptides in Cosmetics Annual Revenue by Company (2019-2024)
3.2.1 Global Bioactive Peptides in Cosmetics Revenue by Company (2019-2024)
3.2.2 Global Bioactive Peptides in Cosmetics Revenue Market Share by Company (2019-2024)
3.3 Global Bioactive Peptides in Cosmetics Sale Price by Company
3.4 Key Manufacturers Bioactive Peptides in Cosmetics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bioactive Peptides in Cosmetics Product Location Distribution
3.4.2 Players Bioactive Peptides in Cosmetics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Bioactive Peptides in Cosmetics by Geographic Region
4.1 World Historic Bioactive Peptides in Cosmetics Market Size by Geographic Region (2019-2024)
4.1.1 Global Bioactive Peptides in Cosmetics Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Bioactive Peptides in Cosmetics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Bioactive Peptides in Cosmetics Market Size by Country/Region (2019-2024)
4.2.1 Global Bioactive Peptides in Cosmetics Annual Sales by Country/Region (2019-2024)
4.2.2 Global Bioactive Peptides in Cosmetics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Bioactive Peptides in Cosmetics Sales Growth
4.4 APAC Bioactive Peptides in Cosmetics Sales Growth
4.5 Europe Bioactive Peptides in Cosmetics Sales Growth
4.6 Middle East & Africa Bioactive Peptides in Cosmetics Sales Growth
5 Americas
5.1 Americas Bioactive Peptides in Cosmetics Sales by Country
5.1.1 Americas Bioactive Peptides in Cosmetics Sales by Country (2019-2024)
5.1.2 Americas Bioactive Peptides in Cosmetics Revenue by Country (2019-2024)
5.2 Americas Bioactive Peptides in Cosmetics Sales by Type (2019-2024)
5.3 Americas Bioactive Peptides in Cosmetics Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bioactive Peptides in Cosmetics Sales by Region
6.1.1 APAC Bioactive Peptides in Cosmetics Sales by Region (2019-2024)
6.1.2 APAC Bioactive Peptides in Cosmetics Revenue by Region (2019-2024)
6.2 APAC Bioactive Peptides in Cosmetics Sales by Type (2019-2024)
6.3 APAC Bioactive Peptides in Cosmetics Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bioactive Peptides in Cosmetics by Country
7.1.1 Europe Bioactive Peptides in Cosmetics Sales by Country (2019-2024)
7.1.2 Europe Bioactive Peptides in Cosmetics Revenue by Country (2019-2024)
7.2 Europe Bioactive Peptides in Cosmetics Sales by Type (2019-2024)
7.3 Europe Bioactive Peptides in Cosmetics Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bioactive Peptides in Cosmetics by Country
8.1.1 Middle East & Africa Bioactive Peptides in Cosmetics Sales by Country (2019-2024)
8.1.2 Middle East & Africa Bioactive Peptides in Cosmetics Revenue by Country (2019-2024)
8.2 Middle East & Africa Bioactive Peptides in Cosmetics Sales by Type (2019-2024)
8.3 Middle East & Africa Bioactive Peptides in Cosmetics Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bioactive Peptides in Cosmetics
10.3 Manufacturing Process Analysis of Bioactive Peptides in Cosmetics
10.4 Industry Chain Structure of Bioactive Peptides in Cosmetics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bioactive Peptides in Cosmetics Distributors
11.3 Bioactive Peptides in Cosmetics Customer
12 World Forecast Review for Bioactive Peptides in Cosmetics by Geographic Region
12.1 Global Bioactive Peptides in Cosmetics Market Size Forecast by Region
12.1.1 Global Bioactive Peptides in Cosmetics Forecast by Region (2025-2030)
12.1.2 Global Bioactive Peptides in Cosmetics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Bioactive Peptides in Cosmetics Forecast by Type (2025-2030)
12.7 Global Bioactive Peptides in Cosmetics Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Active Peptide Company
13.1.1 Active Peptide Company Company Information
13.1.2 Active Peptide Company Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.1.3 Active Peptide Company Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Active Peptide Company Main Business Overview
13.1.5 Active Peptide Company Latest Developments
13.2 Croda International
13.2.1 Croda International Company Information
13.2.2 Croda International Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.2.3 Croda International Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Croda International Main Business Overview
13.2.5 Croda International Latest Developments
13.3 Ashland
13.3.1 Ashland Company Information
13.3.2 Ashland Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.3.3 Ashland Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Ashland Main Business Overview
13.3.5 Ashland Latest Developments
13.4 DSM
13.4.1 DSM Company Information
13.4.2 DSM Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.4.3 DSM Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 DSM Main Business Overview
13.4.5 DSM Latest Developments
13.5 Bachem
13.5.1 Bachem Company Information
13.5.2 Bachem Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.5.3 Bachem Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bachem Main Business Overview
13.5.5 Bachem Latest Developments
13.6 GenScript
13.6.1 GenScript Company Information
13.6.2 GenScript Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.6.3 GenScript Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GenScript Main Business Overview
13.6.5 GenScript Latest Developments
13.7 AmbioPharm
13.7.1 AmbioPharm Company Information
13.7.2 AmbioPharm Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.7.3 AmbioPharm Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 AmbioPharm Main Business Overview
13.7.5 AmbioPharm Latest Developments
13.8 LifeTein
13.8.1 LifeTein Company Information
13.8.2 LifeTein Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.8.3 LifeTein Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 LifeTein Main Business Overview
13.8.5 LifeTein Latest Developments
13.9 Creative Peptides
13.9.1 Creative Peptides Company Information
13.9.2 Creative Peptides Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.9.3 Creative Peptides Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Creative Peptides Main Business Overview
13.9.5 Creative Peptides Latest Developments
13.10 RS Synthesis
13.10.1 RS Synthesis Company Information
13.10.2 RS Synthesis Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.10.3 RS Synthesis Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 RS Synthesis Main Business Overview
13.10.5 RS Synthesis Latest Developments
13.11 Bio Basic
13.11.1 Bio Basic Company Information
13.11.2 Bio Basic Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.11.3 Bio Basic Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Bio Basic Main Business Overview
13.11.5 Bio Basic Latest Developments
13.12 BASF
13.12.1 BASF Company Information
13.12.2 BASF Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.12.3 BASF Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 BASF Main Business Overview
13.12.5 BASF Latest Developments
13.13 Activotec
13.13.1 Activotec Company Information
13.13.2 Activotec Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.13.3 Activotec Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Activotec Main Business Overview
13.13.5 Activotec Latest Developments
13.14 PolyPeptide
13.14.1 PolyPeptide Company Information
13.14.2 PolyPeptide Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.14.3 PolyPeptide Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 PolyPeptide Main Business Overview
13.14.5 PolyPeptide Latest Developments
13.15 Zhejiang Peptites Biotech
13.15.1 Zhejiang Peptites Biotech Company Information
13.15.2 Zhejiang Peptites Biotech Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.15.3 Zhejiang Peptites Biotech Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Zhejiang Peptites Biotech Main Business Overview
13.15.5 Zhejiang Peptites Biotech Latest Developments
13.16 Shenzhen Winkey Technology
13.16.1 Shenzhen Winkey Technology Company Information
13.16.2 Shenzhen Winkey Technology Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.16.3 Shenzhen Winkey Technology Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Shenzhen Winkey Technology Main Business Overview
13.16.5 Shenzhen Winkey Technology Latest Developments
13.17 Guangdong Jianyuan Pharmaceutical
13.17.1 Guangdong Jianyuan Pharmaceutical Company Information
13.17.2 Guangdong Jianyuan Pharmaceutical Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.17.3 Guangdong Jianyuan Pharmaceutical Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Guangdong Jianyuan Pharmaceutical Main Business Overview
13.17.5 Guangdong Jianyuan Pharmaceutical Latest Developments
13.18 Shenzhen Readline Biotech
13.18.1 Shenzhen Readline Biotech Company Information
13.18.2 Shenzhen Readline Biotech Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.18.3 Shenzhen Readline Biotech Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Shenzhen Readline Biotech Main Business Overview
13.18.5 Shenzhen Readline Biotech Latest Developments
13.19 National Peptide Biotechnology
13.19.1 National Peptide Biotechnology Company Information
13.19.2 National Peptide Biotechnology Bioactive Peptides in Cosmetics Product Portfolios and Specifications
13.19.3 National Peptide Biotechnology Bioactive Peptides in Cosmetics Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 National Peptide Biotechnology Main Business Overview
13.19.5 National Peptide Biotechnology Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂